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Clostridium d@icile toxin A was purified to homogeneity and was used to raise monospecific antiserum in 
rabbits. A gene bank of C. diffile DNA in Escherichia coli was constructed by cloning Sau3A-cleaved clos- 
tridial DNA fragments into the bacteriophage vector IEMBL3. Out of 4500 plaques screened with antitoxin 
A, 9 clones were positively identified. One of these clones ltA5 expressed a235 kDa protein which exhibited 
a cytotonic effect on Chinese hamster ovary cells, and had the ability to haemagglutinate rabbit erythro- 
cytes, both properties characteristic of toxin A. The size of the ltA5 insert DNA was 14.3 kb. 
Toxin A; Molecular cloning; Pseudomembranous colitis; (Clostridium d@ciIe) 
1. INTRODUCTION 
Clostridium difficile has been shown to be the 
causative agent of pseudomembranous colitis and 
antibiotic-associated colitis and diarrhoea in 
humans and animals [l-4]. The pathogenicity of 
this organism has been linked to its toxin produc- 
ing capabilities [1,3]. It appears to elaborate at 
least two toxins; toxin A which is an enterotoxin 
capable of inducing fluid accumulation in the rab- 
bit ileal loop assay, and toxin B which is a potent 
cytotoxin [5,6]. Toxin A also exhibits cytotoxic ac- 
tivities [3,6] and had a cytotonic effect on Chinese 
hamster ovary (CHO) cells [7]. Both toxins also 
have the ability to haemagglutinate rabbit 
erythrocytes [8,9]. 
Much controversy exists concerning the 
biochemical composition of toxin A such as amino 
acid content [lo- 121, isoelectric points [ 10,131 and 
relative molecular mass (estimates range from 57 
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to 600 kDa [6,7,12-161). The molecular cloning of 
toxin A will provide more definitive information 
on the polypeptide’s tructure and mode of action. 
Furthermore, highly purified toxin A and antitoxin 
A sera are necessary in the development of reliable 
detection systems for toxigenic strains of C. dif 
ficile. 
Recently, Muldrow et al. [17] have reported the 
cloning of a toxin A gene fragment in hgt 11, but no 
biological activity of the toxin was observed. In 
our study C. difficile toxin A was cloned and ex- 
pressed in E. coli K12, using the bacteriophage 
replacement cloning vector XEMBL3. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains 
An isolate of C. difficile (Wl) obtained from a 
patient with pseudomembranous colitis at this 
hospital was used for the purification of toxin A 
and the construction of a gene library of C. dif- 
ficile DNA. The identity of the strain was con- 
firmed by smell, morphology, fluorescence under 
UV and gas-liquid chromatographic analysis of 
volatile fatty acids. E. coli K12 392 (lysogenic for 
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phage P2) was used as the host strain for cloning 
manipulations [ 181. 
2.2. Purification of toxin A 
A 5 1 growth of C. difficile was cultured as 
described by Redmond et al. [19]. Toxin A was 
purified from the culture filtrate by 40% am- 
monium sulphate precipitation, preparative elec- 
trophoresis using a discontinuous buffer system 
and by ion-exchange chromatography on a DEAE- 
Sepharose CL-6B column [19]. The purified toxin 
A produced a single band on SDS-PAGE analysis 
and caused significant fluid accumulation in the 
rabbit ileal loop assay [19]. 
2.3. Antitoxin A preparation 
Antisera to toxin A was raised in 3 kg male 
Californian rabbits by the procedure of Redmond 
et al. [ 191. Antitoxin A used for screening recombi- 
nant clones was adsorbed at least three times with 
whole cell and XEMBL3 lysed E. coli cells to 
remove non-specific antibodies. 
2.4. Construction of C. difficile gene library 
C. difficile genomic DNA was prepared by a 
method developed in this laboratory [20]. C. dif- 
ficile DNA was partially digested with Sau3A (pro- 
ducing fragments of approx. 9-20 kb in size) and 
ligated into BamHI-digested hEMBL3 DNA. After 
ligation, the gene library was packaged (Gigapack 
kit, NBL, Cramlington, England) and screened 
directly without amplification. 
2.5. Screening of C. difficile gene library 
The C. difficile gene library was screened for 
toxin A positive recombinants by a method similar 
to that described by Russell et al. [21]. The gene 
library was plated on E. coli K12,392 to give ap- 
prox. 300 plaques per 90 mm diameter plate. 
Gridded nitrocellulose filter discs (Schleicher and 
Schuell, England) were overlaid on agar plates and 
left in contact at 4°C for 1 h to adsorb antigenic 
products from the recombinant clones. The 
nitrocellulose was removed from the agar and ex- 
cess sites were blocked with 3% bovine serum 
albumin (BSA) in buffered saline (0.9% NaCl, 
IO mM Tris; pH 7.4). The nitrocellulose was in- 
cubated at 25°C for 2 h with E. coli adsorbed toxin 
A antiserum, diluted 1: 100 in 3% BSA solution. 
The incubation with the anti-rabbit IgG and 
visualisation of the immunoreactive protein pro- 
duct were performed as described in [22]. The posi- 
tion of the plaques which reacted immunogenically 
with antitoxin A were identified on the original 
agar plates. The positive plaques were picked and 
stored in 0.5 ml SM buffer (0.1 M NaCl, 10 mM 
MgS04, 50 mM Tris (pH 7.5), 0.01% gelatine) and 
20 yl chloroform. Samples for immunoblot 
analysis and biological assays were obtained from 
single plaques after plating each with E. coli to 
produce a lawn of confluent lysis. Lawns were 
overlaid with SM buffer (0.25 ml) for 1 h at 25°C 
and harvested. 
2.6. SDS-PAGE and immunoblotting 
SDS-PAGE, electrophoretic transfer (im- 
munoblotting) and the development of im- 
munoreactive protein products was performed as 
described in [22]. 
2.7. CHO cells assay and neutralisation tests 
Morphological changes of CHO cells were ex- 
amined essentially as described by Katoh et al. [7]. 
c 12 3 2 K 
Fig. 1. Confirmation of cloned toxin A determinant by 
immunoblotting as described in section 2.6. Lanes: (1) 
20~1 of AtA plaque lysate against E. coli adsorbed 
antitoxin A provided by P. Rautenberg [13]; (2) purified 
toxin A (4 pg) against antitoxin A prepared as described 
in section 2.3; (3) 20 pl of XEMBL3 control plaque lysate 
against antitoxin A as lane (2); (4) 20~1 of AtA plaque 
lysate against antitoxin A as lane (2); (5) molecular mass 
marker (7.5 pg) catalase (232 kDa). 
83 
Volume 225, number 1,2 FEBS LETTERS December 1987 
Samples for assay were double diluted in the tissue 
culture test medium and 20~1 volumes of each 
dilution were added to the wells. For neutralisation 
tests, mixtures containing toxin A were incubated 
with doubling dilutions of antitoxin A or C. 
sordellii antitoxin (Wellcome Biotechnology, 
England) for 1 h at 37°C prior to addition to CHO 
cells. 
2.8. Haemagglutination assay 
Samples (20~1) were tested for their ability to 
haemagglutinate rabbit erythrocytes (Sigma, 
England) at 4°C and 37°C by the method de- 
scribed by Franzon and Manning [23]. 
2.9. Isolation of bacteriophage hEA4BL3 DNA 
The plate lysate method [24] was used for the 
isolation of DNA from recombinant hEMBL3 
clones. Restriction endonuclease digestion of 
recombinant XEMBL3 DNA was carried out as 
recommended by the manufacturers (NBL, Cram- 
lington, England). 
3. RESULTS AND DISCUSSION 
A total of 4500 AEMBL3 plaques were screened 
for toxin A antigen-producing recombinants, of 
which 9 reacted positively. One of these clones 
named htA5 was chosen for further study. Extrac- 
tion of DNA from AtA and digestion with BamHI 
or SalI revealed a DNA insert of 14.3 kb. Im- 
munoblot analysis with AtA showed a single pro- 
tein band of M, 235 000 reacting antigenically with 
E. coli adsorbed antitoxin A (fig. 1, lane 4), which 
corresponded to the same relative position for the 
, 
Pig.2. Photomicrographs of CHO cells stained with Giemsa: A, cells treated with 1 pg/ml of toxin A; B, cells treated 
with 8 /g/ml of toxin A; C, cells treated with 20 ~1 of AtA plaque lysate; D, cells treated with 20 ~1 of hEMBL3 control 
plaque lysate. The neutralising effect of antitoxin A and C. sordelfii antitoxin on toxin A andhtA5 plaque lysate resulted 
in the normal appearance of the cells, as in D. 
84 
Volume 225, number 1,2 FEBS LETTERS December 1987 
Fig.3. Haemagglutination of rabbit erythrocytes at 4°C. The wells contain two-fold serial dilutions of toxin A 8 pg/ml 
(first row), 20 ~1 of AtA plaque lysate (second row), 20 ~1 of AEMBL3 control plaque lysate (third row), and untreated 
rabbit erythrocytes (fourth row). The effects of antitoxin A and C. sordellii antitoxin on toxin A and htA5 plaque lysate 
were the same as rows 3 and 4. 
purified toxin A (fig.1, lane 2). No protein bands toxin A and AtA lysate could be inhibited by in- 
were seen for the control hEMBL3 plaque lysate cubating with antitoxin A or C. sordellii antitoxin 
(fig.1, lane 3). Rautenberg and Stender [13] have for 1 h prior to the addition of rabbit erythrocytes 
reported toxin A as having an M, value of 230000 (not shown). Krivan et al. [8] have reported the 
when tested by SDS-PAGE, which corresponds ability of toxin A to bind avidly to rabbit 
closely to the protein product of AtA of M, erythrocytes, particularly at 4”C, and have pro- 
235000. Furthermore, antitoxin A, kindly pro- posed that the binding site for toxin A in the gut 
vided by P. Rautenberg, cross-reacts with AtA in may be similar to outer membrane carbohydrate 
the 230-235 kDa region (fig.1, lane 1). moieties from rabbit erythrocytes. 
Incubation of toxin A (1 pg/ml) and XtA5 lysate 
(20 ~1) with CHO cells caused them to elongate 
(fig.2A,C). This cytotonic effect was not observed 
using the control XEMBL3 plaque lysates (fig.2D), 
and could be completely neutralised for purified 
and cloned toxin A using antitoxin A or C. 
sordellii antitoxin where the CHO cells appeared 
normal. At higher concentrations of toxin A 
(>5 pug/ml) a cytotoxic effect was observed where 
the toxin destroys the CHO cells and the cytotonic 
effect is masked (fig.2B). Using 100~1 of htA5 
rounding up of cells was partially visible (un- 
published). Katoh et al. [7] have also reported a 
cytotonic effect using low concentrations of toxin 
A (0.9-3.6pg/ml) and similar effects on CHO 
cells have been shown to be induced by cholera 
enterotoxin [25] and enterotoxigenic E. coli heat- 
labile enterotoxin [26]. 
A previous report [ 171 concerning the cloning of 
toxin A demonstrated that a clone, designated 
ACd25, carrying a 0.3 kb DNA fragment, encoded 
a protein which reacted antigenically with antitox- 
in A on immunoblotting, although no molecular 
mass estimate for the protein was given [ 171. The 
authors’ clone, hCd25, showed no toxic effects on 
tissue culture cells, in contrast to AtA described in 
this paper. This may be related to the fact that 
AtA has a larger DNA insert than hCd25, 14.3 kb 
compared with 0.3 kb, and is therefore more likely 
to contain the genetic information necessary for 
the expression of toxin A. This study has 
demonstrated that C. difficile toxin A can be con- 
veniently cloned and expressed in E. coli using the 
A bacteriophage vector EMBL3. 
Purified toxin A (5 pg/ml) and htA5 lysate 
(20 ,ul) caused significant haemagglutination when 
incubated with rabbit erythrocytes at 4°C (fig.3). 
This effect was diminished when the microtitre 
plates were incubated at 37°C and no effect was 
seen with the control plaque XEMBL3 at 4°C or 
37°C. The haemagglutinating effect of purified 
ACKNOWLEDGEMENTS 
This work was supported by the Wellcome Trust 
and the Medical Research Council, England. We 
are grateful to J. Stephen, J. Ketley and T. Mit- 
chell for assistance and advice in the preparation 
of toxin A. We thank Mrs C. Whitfield for typing 
the manuscript. 
85 
Volume 225, number 1,2 FEBS LETTERS December 1987 
REFERENCES 
[l] Bartlett, J.P., Onderdonk, A.B., Cisneros, R.L. 
and Kasper, D.L. (1977) J. Infect. Dis. 136, 
701-70s. 
[2] Bartlett, J.G. (1981) Johns Hopkins Med. J. 149, 
6-9. 
[3] Larson, H.E. and Price, A.B. (1977) Lancet ii, 
1312-1314. 
[4] Rothman, S.W. (1981) Med. Microbial. Immunol. 
169, 187-196. 
[5] Taylor, N.S., Thorne, G.M. and Bartlett, J.G. 
(1981) Infect. Immun. 34, 1036-1043. 
[6] Libby, J.M. and Wilkins, T.D. (1982) Infect. 
Immun. 35, 374-376. 
[7] Katoh, T., Higaki, M., Honda, T. and Miwatani, 
T. (1986) FEMS Microbial. Lett. 34, 241-244. 
[8] Krivan, H.C., Clark, G.C., Smith, D.F. and 
Wilkins, T.D. (1986) Infect. Immun. 53, 573-581. 
[9] Thelestam, M. and Florin, I. (1984) J. Toxicol. 
Toxin Rev. 3, 139-180. 
[lo] Lyerly, D.M., Roberts, M.D., Phelps, C.J. and 
Wilkins, T.D. (1986) FEMS Microbial. Lett. 33, 
31-35. 
[ 1 l] Stephen, J., Redmond, S.C., Mitchell, T. J., 
Ketley, J., Candy, D.C.A., Burdon, D.W. and 
Daniel, R. (1984) Biochem. Sot. Trans. 12, 
194-195. 
[12] Banno, Y., Kobayashi, T., Kono, H., Watanabe, 
K., Ueno, K. and Nozawa, Y. (1984) Infect. Dis. 6, 
s 11 -s20. 
[13] Rautenberg, P. and Stender, F. (1986) FEMS 
Microbial. Lett. 37, 1-7. 
[14] Banno, Y., Kobayashi, T., Kono, H., Watanabe, 
K., Ueno, K. and Nozawa, Y. (1981) Biochem. Int. 
6, 629-635. 
[15] Rihn, B., Scheftel, J.M., Girardot, R. and Monteil, 
H. (1984) Biochem. Biophys. Res. Commun. 124, 
690-695. 
[16] Aronsson, B., Mollby, R. and Nord, C.E. (1982) 
Stand. J. Infect. Dis. supp1.35, 53-58. 
[ 171 Muldrow, L.L., Ibeanu, G.C., Lee, N.I., Bose, 
N.K. and Johnson, J. (1987) FEBS Lett. 213, 
249-253. 
[18] Glover, D.M. (1985) in: DNA Cloning; A Practical 
Approach, ~01.1, IRL Press, Oxford. 
[19] Redmond, S.C., Ketley, J.M., Mitchell, T. J., 
Stephen, J., Burdon, D.W. and Candy, D.C.A. 
(1985) in: Isolation and Identification of 
Microorganisms of Medical and Veterinary 
Importance (Collins, C.H. et al, eds) pp.237-250, 
Academic Press, London. 
[20] Wren, B.W. and Tabaqchali, S. (1987) J. Clin. 
Microbial., in press. 
[21] Russell, R.R., Coleman, D. and Dougan, G. (1985) 
J. Gen. Microbial. 131, 295-299. 
[22] Heard, S.R., Rasbum, B., Matthews, R.C. and 
Tabaqchali, S. (1986) J. Clin. Microbial. 24, 
384-387. 
[23] Franzon, V.L. and Manning, P.A. (1986) Infect. 
Immunol. 52, 279-284. 
[24] Maniatis, T., Fritsch, E.F. and Sambrook, J. 
(1982) Molecular Cloning, Cold Spring Harbour 
Laboratory, Cold Spring Harbour, NY. 
[25] Guerrant, R.L., Bruton, L.L., Schnaiman, T.C., 
Rebhum, L.I. and Gilman, A.G. (1974) Infect. 
Immun. 10, 320-327. 
[26] Honda, T., Shimizu, M., Takeda, Y. and 
Miwatani, T. (1976) Infect. Immun. 14. 
1028-1033. 
86 
